Coexistence of non-specific and usual interstitial pneumonia in a patient with severe cystic scleroderma lung involvement and parvovirus B19 infection [7]

Clinical and Experimental Rheumatology

Volumn 23, Issue 3, 2005, Pages 431-433

  Ghinoi, A ^a   Mascia, M T ^a   Giuggioli, D ^a   Magistro, R ^a   Barbolini, G ^a   Magro, C M ^b   Ferri, Clodoveo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE;

ADULT; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ERYTHEMA INFECTIOSUM; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; INTERSTITIAL PNEUMONIA; LETTER; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LYMPHANGIOLEIOMYOMATOSIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SCLERODERMA; SPIROMETRY; SYSTEMIC SCLEROSIS; THORACOSCOPY;

ADULT; ANTIRHEUMATIC AGENTS; CYCLOPHOSPHAMIDE; CYSTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; LYMPHANGIOLEIOMYOMATOSIS; METHYLPREDNISOLONE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RADIOGRAPHY, THORACIC; SCLERODERMA, SYSTEMIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 20444472756     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (12)

1. FERRI C, VALENTINI G, COZZI F et al.: Systemic sclerosis: Demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002; 81: 139-53.
2. BOUROS D, WELLS AU, NICHOLSON AG et al.: Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 15; 165: 1581-6.
3. FUJITA J, YOSHINOUCHI T, OHTSUKI Y et al.: Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis. Ann Rheum Dis 2001; 60: 281-3.
4. PACIOCCO G, USLENGHI E, BIANCHI A et al.: Diffuse cystic lung diseases: correlation between radiologic and functional status. Chest 2004; 125: 135-42.
5. FERRI C, ZAKRZEWSKA K, LONGOMBARDO G et al.: Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 1999; 17: 718-20.
6. MAGRO CM, NUOVO G, FERRI C, CROWSON AN, GIUGGIOLI D, SEBASTIANI M: Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. J Cutan Pathol 2004; 31: 43-50.
7. GETZOVA S: Cystic and compact pulmonary sclerosis in progressive scleroderma. Arch Pathol 1945; 40: 99-106.
8. BERGEMANN A, TIKLY M: Cystic lung disease in systemic sclerosis: A case report with high resolution computed tomography findings. Rev Rhum (Engl ed.) 1996; 63: 213-5.
9. ZEUNER M, MULLER-LADNER U, MOHR VD, LANG B: Spontaneous pneumothorax in a patient with systemic sclerosis. Clin Rheumatol 1996; 15: 211-3.
10. FLAHERTY KR, TRAVIS WD, COLBY TV et al.: Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164: 1722-7.
11. FERRI C, GIUGGIOLI D, SEBASTIANI M et al.: Parvovirus B19 infection of cultured skin fibroblasts from systemic sclerosis patients. Arthritis Rheum 2002; 46: 2262-3.
12. OHTSUKA T, YAMAZAKI S: Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin. Br J Dermatol 2004; 150: 1091-5.